🚀 VC round data is live in beta, check it out!
- Public Comps
- Core Laboratories
Core Laboratories Valuation Multiples
Discover revenue and EBITDA valuation multiples for Core Laboratories and similar public comparables like Hallador Energy, Greenfire Resources, PetroRecĂ´ncavo, WIP Terminal and more.
Core Laboratories Overview
About Core Laboratories
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Founded
1936
HQ

Employees
3.5K
Website
Sectors
Financials (LTM)
EV
$920M
Core Laboratories Financials
Core Laboratories reported last 12-month revenue of $521M and EBITDA of $72M.
In the same LTM period, Core Laboratories generated $115M in gross profit, $72M in EBITDA, and $34M in net income.
Revenue (LTM)
Core Laboratories P&L
In the most recent fiscal year, Core Laboratories reported revenue of $527M and EBITDA of $73M.
Core Laboratories expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $521M | XXX | $527M | XXX | XXX | XXX |
| Gross Profit | $115M | XXX | $94M | XXX | XXX | XXX |
| Gross Margin | 22% | XXX | 18% | XXX | XXX | XXX |
| EBITDA | $72M | XXX | $73M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $34M | XXX | $35M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | — | — | $88M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Core Laboratories Stock Performance
Core Laboratories has current market cap of $779M, and enterprise value of $920M.
Market Cap Evolution
Core Laboratories' stock price is $16.92.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $920M | $779M | 2.8% | XXX | XXX | XXX | $0.77 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCore Laboratories Valuation Multiples
Core Laboratories trades at 1.8x EV/Revenue multiple, and 12.8x EV/EBITDA.
EV / Revenue (LTM)
Core Laboratories Financial Valuation Multiples
As of April 18, 2026, Core Laboratories has market cap of $779M and EV of $920M.
Equity research analysts estimate Core Laboratories' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Core Laboratories has a P/E ratio of 22.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $779M | XXX | $779M | XXX | XXX | XXX |
| EV (current) | $920M | XXX | $920M | XXX | XXX | XXX |
| EV/Revenue | 1.8x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 12.8x | XXX | 12.5x | XXX | XXX | XXX |
| EV/EBIT | 16.6x | XXX | 15.7x | XXX | XXX | XXX |
| EV/Gross Profit | 8.0x | XXX | 9.8x | XXX | XXX | XXX |
| P/E | 22.9x | XXX | 22.1x | XXX | XXX | XXX |
| EV/FCF | 33.6x | XXX | 40.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Core Laboratories Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Core Laboratories Margins & Growth Rates
Core Laboratories' revenue in the last 12 month declined by (1%).
Core Laboratories' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Core Laboratories' rule of 40 is 10% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Core Laboratories' rule of X is 5% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Core Laboratories Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (1%) | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | (1%) | XXX | (7%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 10% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 5% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 9% | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 8% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Core Laboratories Public Comps
See public comps and valuation multiples for other Energy Equipment and Oil & Gas comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Core Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Hallador Energy | XXX | XXX | XXX | XXX | XXX | XXX |
| Greenfire Resources | XXX | XXX | XXX | XXX | XXX | XXX |
| PetroRecĂ´ncavo | XXX | XXX | XXX | XXX | XXX | XXX |
| WIP Terminal | XXX | XXX | XXX | XXX | XXX | XXX |
| Vitesse Energy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Core Laboratories M&A Activity
Core Laboratories acquired XXX companies to date.
Last acquisition by Core Laboratories was on XXXXXXXX, XXXXX. Core Laboratories acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Core Laboratories
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCore Laboratories Investment Activity
Core Laboratories invested in XXX companies to date.
Core Laboratories made its latest investment on XXXXXXXX, XXXXX. Core Laboratories invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Core Laboratories
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Core Laboratories
| When was Core Laboratories founded? | Core Laboratories was founded in 1936. |
| Where is Core Laboratories headquartered? | Core Laboratories is headquartered in United States. |
| How many employees does Core Laboratories have? | As of today, Core Laboratories has over 3K employees. |
| Who is the CEO of Core Laboratories? | Core Laboratories' CEO is Lawrence Bruno. |
| Is Core Laboratories publicly listed? | Yes, Core Laboratories is a public company listed on NYSE. |
| What is the stock symbol of Core Laboratories? | Core Laboratories trades under CLB ticker. |
| When did Core Laboratories go public? | Core Laboratories went public in 1995. |
| Who are competitors of Core Laboratories? | Core Laboratories main competitors are Hallador Energy, Greenfire Resources, PetroRecĂ´ncavo, WIP Terminal. |
| What is the current market cap of Core Laboratories? | Core Laboratories' current market cap is $779M. |
| What is the current revenue of Core Laboratories? | Core Laboratories' last 12 months revenue is $521M. |
| What is the current revenue growth of Core Laboratories? | Core Laboratories revenue growth (NTM/LTM) is (1%). |
| What is the current EV/Revenue multiple of Core Laboratories? | Current revenue multiple of Core Laboratories is 1.8x. |
| Is Core Laboratories profitable? | Yes, Core Laboratories is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Core Laboratories? | Core Laboratories' last 12 months EBITDA is $72M. |
| What is Core Laboratories' EBITDA margin? | Core Laboratories' last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Core Laboratories? | Current EBITDA multiple of Core Laboratories is 12.8x. |
| What is the current FCF of Core Laboratories? | Core Laboratories' last 12 months FCF is $27M. |
| What is Core Laboratories' FCF margin? | Core Laboratories' last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Core Laboratories? | Current FCF multiple of Core Laboratories is 33.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.